Royal Bank Of Canada Issues Positive Forecast for Corteva (NYSE:CTVA) Stock Price

Corteva (NYSE:CTVA) had its price objective upped by Royal Bank Of Canada from $80.00 to $89.00 in a research note issued on Thursday, MarketBeat reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price points to a potential upside of 22.14% from the company’s previous close.

Other equities analysts have also issued research reports about the stock. UBS Group dropped their target price on shares of Corteva from $85.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday, October 30th. Bank of America raised their price objective on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price target on shares of Corteva in a research note on Thursday. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 22nd. Finally, BNP Paribas Exane upped their price target on shares of Corteva from $70.00 to $72.00 and gave the company a “neutral” rating in a research note on Monday, November 17th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.11.

Corteva Trading Down 3.0%

CTVA stock traded down $2.25 during trading on Thursday, reaching $72.87. The company had a trading volume of 931,482 shares, compared to its average volume of 3,876,970. Corteva has a 52 week low of $53.40 and a 52 week high of $77.41. The company has a market cap of $49.24 billion, a P/E ratio of 46.24, a PEG ratio of 1.91 and a beta of 0.75. The business has a 50 day moving average of $68.60 and a 200 day moving average of $68.40. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.07.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 8.97%. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts forecast that Corteva will post 2.96 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in CTVA. Chilton Capital Management LLC increased its holdings in shares of Corteva by 18.1% in the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock valued at $30,119,000 after purchasing an additional 68,380 shares during the period. TriaGen Wealth Management LLC purchased a new stake in shares of Corteva in the 3rd quarter valued at $4,284,000. New York State Teachers Retirement System raised its holdings in shares of Corteva by 4.5% during the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock worth $37,290,000 after purchasing an additional 23,548 shares during the last quarter. Truist Financial Corp boosted its holdings in Corteva by 4.5% in the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after purchasing an additional 13,910 shares during the last quarter. Finally, Nordea Investment Management AB raised its stake in shares of Corteva by 27.4% during the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock valued at $5,103,000 after buying an additional 16,261 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Management raised FY‑2026 EPS guidance to $3.45–$3.70, above the Street, signaling confidence in margin expansion and growth platforms. Strong 2H and Full Year 2025 Results Driven by Leading Technology, Disciplined Execution
• Positive Sentiment: Company highlighted record free cash flow and disciplined working‑capital management for FY‑2025, which supports buybacks/deployment and reduces execution risk. Corteva Inc (CTVA) Q4 2025 Earnings Call Highlights: Record Free Cash Flow and Strategic …
• Neutral Sentiment: Q4 EPS was $0.22 — roughly in line with consensus and slightly above one estimate — suggesting profitability held up despite revenue pressure. Corteva, Inc. (CTVA) Surpasses Q4 Earnings Estimates
• Neutral Sentiment: Analysts show mixed views on Corteva’s outlook and positioning in materials/agriculture — differing takes add to near‑term volume sensitivity but not a clear directional signal. Analysts Have Conflicting Sentiments on These Materials Companies: Corteva (CTVA) and Southern Copper (SCCO)
• Negative Sentiment: Q4 revenue missed materially: $3.91B vs. estimates near $4.23B; management cited seasonal timing shifts and weaker crop‑protection/seed demand, which pressured the headline and prompted after‑hours selling. Corteva misses quarterly sales estimates
• Negative Sentiment: After‑hours coverage noted a ~3% share drop tied to the seasonal timing/revenue miss, amplifying volatility into the session. Corteva shares fall 3% as seasonal timings shifts drive Q4 revenue miss
• Negative Sentiment: JPMorgan cut its rating from Overweight to Neutral (albeit with a slightly higher $77 PT), a downgrade that can weigh on near‑term sentiment among institutional holders. Benzinga: JPMorgan downgrades Corteva

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.